SM
Srinivas Manthena
About Srinivas Manthena
Data last updated:
Srinivas Manthena is a Director at Actin Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Actin Pharmaceuticals Private Limited reported revenue of ₹60 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Actin Pharmaceuticals Private Limited U47721TS2023PTC171122 | Director | 15 Mar 2023 | 2023 | ₹60 Lakh (FY 2024) | Active |
Board colleagues of Srinivas Manthena
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bonagiri Srinivas | 10073423 | Actin Pharmaceuticals Private Limited | Director |
| Bhoomesh Mydam | 10118479 | Actin Pharmaceuticals Private Limited | Director |
| Gangarapu Sampath | 10073422 | Actin Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivas Manthena
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivas Manthena
Srinivas Manthena currently holds 1 directorship: Actin Pharmaceuticals Private Limited (Director, since 15 Mar 2023, revenue ₹60 Lakh (FY 2024)).
Srinivas Manthena was first appointed on 15 Mar 2023 as Director at Actin Pharmaceuticals Private Limited.
The current boards of Srinivas Manthena's companies include Bonagiri Srinivas (Actin Pharmaceuticals Private Limited), Bhoomesh Mydam (Actin Pharmaceuticals Private Limited), Gangarapu Sampath (Actin Pharmaceuticals Private Limited).